Research Article
Study on the Intervention Effect of Qi Gong Wan Prescription on Patients with Phlegm-Dampness Syndrome of Polycystic Ovary Syndrome Based on Intestinal Flora
Table 1
Anthropometric and metabolic parameters of all participants.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are presented as mean ± SD. Abbreviations: PCOS, polycystic ovary syndrome; BMI, body mass index; WHR, waist-to-hip ratio; FPG, fasting plasma glucose; FINS, fasting plasma insulin; HOMA-IR, homeostasis model assessment of insulin resistance; FSH, follicular stimulating hormone; LH, luteinizing hormone; , PCOS with phlegm-dampness group vs. PCOS with nonphlegm-dampness group; , PCOS with phlegm-dampness group vs. control group; , PCOS with nonphlegm-dampness group vs. control group. NS: there was no significant difference among the three groups, > 0.05; the difference was statistically significant, < 0.05. There is a significant difference between the two groups (<0.05); difference is highly significant (<0.01). |